• About us
  • People
  • Expertise
    • Sectors
        • Technology, media & communications Technology, media & communications
        • Private Wealth Private wealth
        • Real estate, infrastructure & energy
        • Life sciences & healthcare icon Life sciences & healthcare
        • Aerospace & defence
        • Automotive & mobility
        • Business & professional services
        • Chemicals
        • Consumer & retail
        • Financial institutions & insurance
        • Hotels, hospitality & leisure
        • Logistics & transport
        • Manufacturing & industrials
        • Public services & education
    • Legal services
        • Artificial intelligence
        • Banking & finance
        • Brands & advertising
        • Commercial & consumer contracts
        • Competition, EU & trade
        • Copyright & media law
        • Corporate crime & compliance
        • Corporate/M&A & capital markets
        • Data & cyber
        • Disputes & investigations
        • Employment, pensions & mobility
        • Environmental, planning & regulatory
        • Environmental, social & governance (ESG)
        • Intellectual property
        • Information technology
        • Patents & innovation
        • Private client
        • Private equity
        • Projects, energy & infrastructure
        • Real estate & construction
        • Regulation
        • Restructuring & insolvency
        • Tax
        • Venture capital
  • Locations
    • Europe
        • Locations
        • Austria
        • Belgium
        • Czech Republic
        • France
        • Germany
        • Hungary
        • Italy
        • Netherlands
        • Poland
        • Portugal
        • Ireland
        • Slovakia
        • Spain
        • United Kingdom
        • Ukraine
          Groups & regions
        • CEE Turkish Desk
        • French German group
        • Our offices
    • Middle East & Africa
        • Locations
        • Middle East
        • UAE
          Groups
        • Africa group
        • Israel group
        • Our offices
    • Americas
        • Locations
        • Latin America
        • USA
          Groups
        • Brazil group
        • Our offices
    • Asia
        • Locations
        • Asia
        • China
        • South Korea
          Groups
        • India group
        • Japan group
        • Our offices
  • Insights
    • Insights
        • Featured Topics
        • Artificial intelligence
        • Data Centre Expertise
        • The EU Whistleblower Directive
        • German Supply Chain Act
        • Unified Patent Court
          Content hub
        • Global Data Hub
        • Interface: tech, IP and media law
        • Podcasts
        • Synapse
        • Browse all insights
    • In focus
        • AI
        • Dealonomics
        • Disputes
        • Intellectual property
        • MENA
        • Regulation
        • Browse in focus
    • Events
        • In person
        • Online
        • Browse all events
    • News
        • Media centre
        • Work highlights
        • Firm news
        • Browse all news
  • Careers
  • EN
    • English
    • 中文(简体)
    • Français
    • Deutsch
  • Home
  • People
  • Claudia Vander Velde
Claudia Vander Velde
Claudia Vander Velde

Claudia Vander Velde

Associate

  • Brussels Belgium
Contact Me Today
+32 472 28 89 06
vCard
Email me Call me

Claudia Vander Velde is a trainee patent attorney in the Intellectual Property practice group and specialises in patent litigation.

Claudia has a multidisciplinary background combining law and science with a particular focus on the life sciences. She specialises in intellectual property law, with a strong emphasis on patent law across a range of technical fields, including but not limited to the life sciences. She also advises on copyright, trademark, and design rights.

She has prior experience at the European Commission, where she worked on the REACH chemicals regulation, as well as experience on setting up clinical trials at a CRO, gaining insight into specific challenges of the pharmaceutical industry.

Fluent in French, Dutch, English, and Spanish, Claudia supports clients in an international and multilingual context.

 
 

Expertise

Services and Groups

Brands & advertising
Copyright & media law
Patents & innovation

Sectors

Technology, media & communications
Life sciences & healthcare
Business & professional services

CV

Since 2025 Patent attorney (trainee) | Associate, Taylor Wessing
2023-2024 Regulatory specialist, clinical trials, Fortrea
2022-2023 Trainee, European Commission, DG Grow - REACH unit
2023 LLM European Law, Maastricht University, Maastricht
2021 Bsc, Health and Technology with a specialisation in Biology, Sorbonne University, Paris
2021 LLB, Panthéon-Assas University, Paris

Career

Since 2025 Patent attorney (trainee) | Associate, Taylor Wessing
2023-2024 Regulatory specialist, clinical trials, Fortrea
2022-2023 Trainee, European Commission, DG Grow - REACH unit

Education

2023 LLM European Law, Maastricht University, Maastricht
2021 Bsc, Health and Technology with a specialisation in Biology, Sorbonne University, Paris
2021 LLB, Panthéon-Assas University, Paris

Additional languages

English Dutch French Spanish

Related news & insights

FinTech Stories
Fintech

#7: State of the EU Crypto Industry: MiCA, Tokenisation and What Comes Next

22 April 2026

by Miroslav Đurić, LL.M.

Click here to find out more
Color pencils

Online coaching and distance learning: Federal Court of Justice clarifies application of the Distance Learning Protection Act

21 April 2026
Briefing

by multiple authors

Click here to find out more
China

China’s 2025 Trademark Law (Draft Revision): Key Amendments & Practical Impacts

15 April 2026
Briefing

by Min Dai

Click here to find out more
ivdr mdr
Medical devices

Proposed Amendments to the EU Medical Device Regulation

15 April 2026
Briefing

by Bartosz Świdrak

Click here to find out more
biotech helix
Biotech

Impact of the new Biotech Act on Clinical Trials in the EU

15 April 2026
Quick read

by Irina Rebin

Click here to find out more
Life sciences & healthcare

The 2026 Pharma Package: A New Regulatory Framework for Medicinal Products in the EU

15 April 2026
Briefing

by Irina Rebin

Click here to find out more
Flag of the European community
Life sciences & healthcare

Life Sciences Legal Lens – Vol. 1

7 April 2026
Click here to find out more
International life sciences
Artificial intelligence

Hungary opens health data infrastructure for AI development

1 April 2026
Briefing

by János Kopasz, AIGP, CIPP/E, CIPM

Click here to find out more
International life sciences
Life sciences & healthcare

CJEU Ruling Reshapes Poland’s Pharmacy Advertising Rules

1 April 2026
Quick read

by Bartosz Świdrak

Click here to find out more
International life sciences
Medical devices

No claim for damages as a result of participation in clinical drug trials

1 April 2026

by Irina Rebin

Click here to find out more
View all insights

Related people

Belgium
Global
Christian Dekoninck

Christian Dekoninck

Partner

Brussels
+32 2 3202 251
Email me
View profile
Marie Keup

Marie Keup

Partner

Brussels
+32 2 3202 252
Email me
View profile
Laura Coucke

Laura Coucke

Senior Associate

Brussels
+32 2 3202 260
Email me
View profile
Adam Lybaert

Adam Lybaert

Associate

Brussels
+32 28 87 91 42
Email me
View profile
Full team
Christian Dekoninck

Christian Dekoninck

Partner

Brussels
+32 2 3202 251
Email me
View profile
Marie Keup

Marie Keup

Partner

Brussels
+32 2 3202 252
Email me
View profile
Laura Coucke

Laura Coucke

Senior Associate

Brussels
+32 2 3202 260
Email me
View profile
Adam Lybaert

Adam Lybaert

Associate

Brussels
+32 28 87 91 42
Email me
View profile
Wim Maas

Prof. Dr. Wim Maas

Partner

Amsterdam
+31 6 3175 2962
Email me
View profile
Full team

Meet me at

There are no upcoming events

See all events
Subscribe to our latest insights
  • About us
  • Campaigns and online tools
  • News
  • People
  • Expertise
  • Locations
  • Insights
  • Events
  • Media centre
  • Contact
  • Careers
  • Alumni
  • Data protection & privacy policy
  • Cookie policy
  • Legal and regulatory information
  • Regulatory information on costs
  • Complaints procedure for clients
  • Terms of use
  • Anti-slavery statement
  • Environmental
  • Scam emails

© Taylor Wessing